The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
CAR-T Meeting 2021 | CAR-T patient experience: results from the Global Patient Survey
Lorna Warwick, Lymphoma Coalition, Toronto, Canada, discusses the Lymphoma Coalition Bi-Annual Global Patient Survey and the small-scale results of patients that have undergone CAR T-cell therapy. Ms Warwick highlights the differences in the dataset between patients who were qualified for CAR-T therapy but had not yet received it and those that had completed CAR T-cell therapy, as well as the impact of CAR T-cell therapy on patients’ mental health. Ms Warwick also suggests educating patients about CAR T-cell therapy could help address these problems. This interview took place during the 3rd European CAR T-cell Meeting.
